Alpha Profiles · Company Profile

Cytek Biosciences, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/cytek-biosciences-inc

Entity: Public listing published
Primary listing: NASDAQ: CTKB
Verification: Partially verified
Last reviewed: 2026-10-16T04:46:18.168414+00:00

Overview

Alpha's canonical identity and public leadership record for Cytek Biosciences, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

5 public records

Ming Yan, Ph.D.

Chief Technology Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-017479Apr 28, 2026

Philippe Busque, Ph.D.

Senior Vice President, Global Sales and Services

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-017479Apr 28, 2026

Valerie Barnett

Chief Legal Officer and Corporate Secretary

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-017479Apr 28, 2026

Wenbin Jiang, Ph.D.

Chief Executive Officer and President

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-017479Apr 28, 2026

William McCombe

Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-017479Apr 28, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Oct 16, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.